BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Freed DC, Liu Y, Li F, Barrett DF, Xiong W, Ye X, Adler SP, Rupp RE, Wang D, Zhang N, Fu TM, An Z. A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. NPJ Vaccines 2021;6:79. [PMID: 34078915 DOI: 10.1038/s41541-021-00342-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen W, Kim J, Bu W, Board NL, Tsybovsky Y, Wang Y, Hostal A, Andrews SF, Gillespie RA, Choe M, Stephens T, Yang ES, Pegu A, Peterson CE, Fisher BE, Mascola JR, Pittaluga S, Mcdermott AB, Kanekiyo M, Joyce MG, Cohen JI. Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition. Immunity 2022. [DOI: 10.1016/j.immuni.2022.10.003] [Reference Citation Analysis]
2 Talavera-barber M, Flint K, Graber B, Dhital R, Kaptsan I, Medoro AK, Sánchez PJ, Shimamura M. Antibody Titers Against Human Cytomegalovirus gM/gN and gB Among Pregnant Women and Their Infants. Front Pediatr 2022;10:846254. [DOI: 10.3389/fped.2022.846254] [Reference Citation Analysis]
3 Parsons AJ, Ophir SI, Duty JA, Kraus TA, Stein KR, Moran TM, Tortorella D. Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH. Commun Biol 2022;5:387. [PMID: 35468974 DOI: 10.1038/s42003-022-03294-z] [Reference Citation Analysis]